SBP solbec pharmaceuticals limited

chance to crack into market

  1. greenleaf
    3,726 Posts.
    lightbulb Created with Sketch. 218
    clock Created with Sketch.
    16/10/07
    12:04
    Post #: 2898489
    Solbec have been given a great opportunity to repeat the performance of this drug while it was in Phase 1 trial. The phase 1 patient was in end stage renal cell cancer and that patient is still in REMISSION today. Great news for the patient and hopefully for this next patient. Goods news all round. Go SBP and Coramisine
    SBP Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS Veteran executive to help turn Trigg into leading US-based antimony producer
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.